Biopharma · FDA Approvals · Stock
RACC Research Alliance
Research Alliance Corporation III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Catalyst calendar
Dated catalysts for RACC, including recently decided ones.
Nothing scheduled in this window.
Recent first-hand events
Every first-hand event for RACC, newest first.
Instant stream — events appear as soon as they are filed.
No events yet.
Peers by market cap
Companies in the same sector closest to RACC in market value.
SABSSAB BioMarket cap $267.8M
ARCTArcturus TherapeuticsMarket cap $250.7M · 1 tracked drug · 1 upcoming catalyst
OBIOOrchestra BioMedMarket cap $247.5M · 1 tracked drug
HELPCybinMarket cap $246.0M · 1 tracked drug
VYGRVoyager TherapeuticsMarket cap $245.5M · 1 tracked drug
TARAProtaraMarket cap $287.7M · 1 tracked drug · 3 upcoming catalysts
PRLDPrelude TherapeuticsMarket cap $291.1M · 2 tracked drugs · 1 upcoming catalyst
CVCapsoVisionMarket cap $296.5M · 1 tracked drug